ArticlePsychiatry and clinical psychopharmacology2021
The Prevalence of Sarcopenia in Patients with Schizophrenia.
Article in Psychiatry and clinical psychopharmacology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
10 citing papers in PubMed.
- Review
- Visceral Adiposity Is Associated with Elevated Interleukin-1 Receptor Antagonist Levels and Anxiety Symptoms in Schizophrenia.International journal of molecular sciences · 2026Article
- Inflammation and sarcopenia exhibit distinct associations with psychopathology and executive function in schizophrenia.Journal of the Chinese Medical Association : JCMA · 2026Article
- Bridging assessment, biomarkers, and interventions: progress in muscle health research.Frontiers in rehabilitation sciences · 2026Article
- Handgrip and gait metrics as scalable markers of physical health in schizophrenia and alcohol use disorders.Global mental health (Cambridge, England) · 2026Article
- A Study of Nutritional and Sensory Qualities of Pea Protein Isolate Beverages with a View to Their Potential Use in Patients with Psychiatric Disorders.Foods (Basel, Switzerland) · 2025Article
- Association Between Dynapenia/Sarcopenia, Extrapyramidal Symptoms, Negative Symptoms, Body Composition, and Nutritional Status in Patients with Chronic Schizophrenia.Healthcare (Basel, Switzerland) · 2024Article
- A Metamaterial Computational Multi-Sensor of Grip-Strength Properties with Point-of-Care Human-Computer Interaction.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2023Article
- Examining Factors Associated with Dynapenia/Sarcopenia in Patients with Schizophrenia: A Pilot Case-Control Study.Healthcare (Basel, Switzerland) · 2023Article
- Evaluation of the Accuracy of Six Simple Screening Tools for Sarcopenia in Schizophrenic Patients.The journal of nutrition, health & aging · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: In this study, we aimed to investigate the frequency of sarcopenia in patients with schizophrenia and the risk factors that may be associated with sarcopenia. Methods: We recruited 72 schizophrenia patients who had registered in the schizophrenia specialized unit of Çukurova University. The socio-demographic variable form was filled. Each patient underwent physical mass, strength, and performance tests to confirm the diagnosis of sarcopenia (SP), which was made according to the criteria of European Consensus. Results: Mean age of the patients was 39.50 (19-65) years for the possible sarcopenia group and 37.00 (21-65) years for without SP group. Possible sarcopenia was 36.1% ( Conclusion: This is the first study that investigated SP in schizophrenia patients. Sarcopenia was found more frequently in schizophrenia patients than in the general population.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.